Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/133335
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
Author: Bourne, R.
Adelson, J.
Flaxman, S.
Briant, P.S.
Taylor, H.R.
Casson, R.J.
Bikbov, M.M.
Bottone, M.
Braithwaite, T.
Bron, A.
Cheng, C.-Y.
Cicinelli, M.V.
Congdon, N.
Fernandes, A.G.
Friedman, D.S.
Furtado, J.M.
George, R.
Kahloun, R.
Kempen, J.H.
Khairallah, M.
et al.
Citation: The Lancet Global Health, 2021; 9(2):e130-e143
Publisher: Elsevier
Issue Date: 2021
ISSN: 2214-109X
2214-109X
Statement of
Responsibility: 
Rupert R A Bourne ... Robert James Casson ... et al. (GBD 2019 Blindness and Vision Impairment Collaborators on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study)
Abstract: Background: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of global vision impairment in 2020 and temporal change is needed. We aimed to extensively update estimates of global vision loss burden, presenting estimates for 2020, temporal change over three decades between 1990–2020, and forecasts for 2050. Methods: We did a systematic review and meta-analysis of population-based surveys of eye disease from January, 1980, to October, 2018. Only studies with samples representative of the population and with clearly defined visual acuity testing protocols were included. We fitted hierarchical models to estimate 2020 prevalence (with 95% uncertainty intervals [UIs]) of mild vision impairment (presenting visual acuity ≥6/18 and <6/12), moderate and severe vision impairment (<6/18 to 3/60), and blindness (<3/60 or less than 10° visual field around central fixation); and vision impairment from uncorrected presbyopia (presenting near vision <N6 or <N8 at 40 cm where best-corrected distance visual acuity is ≥6/12). We forecast estimates of vision loss up to 2050. Findings: In 2020, an estimated 43·3 million (95% UI 37·6–48·4) people were blind, of whom 23·9 million (55%; 20·8–26·8) were estimated to be female. We estimated 295 million (267–325) people to have moderate and severe vision impairment, of whom 163 million (55%; 147–179) were female; 258 million (233–285) to have mild vision impairment, of whom 142 million (55%; 128–157) were female; and 510 million (371–667) to have visual impairment from uncorrected presbyopia, of whom 280 million (55%; 205–365) were female. Globally, between 1990 and 2020, among adults aged 50 years or older, age-standardised prevalence of blindness decreased by 28·5% (–29·4 to –27·7) and prevalence of mild vision impairment decreased slightly (–0·3%, –0·8 to –0·2), whereas prevalence of moderate and severe vision impairment increased slightly (2·5%, 1·9 to 3·2; insufficient data were available to calculate this statistic for vision impairment from uncorrected presbyopia). In this period, the number of people who were blind increased by 50·6% (47·8 to 53·4) and the number with moderate and severe vision impairment increased by 91·7% (87·6 to 95·8). By 2050, we predict 61·0 million (52·9 to 69·3) people will be blind, 474 million (428 to 518) will have moderate and severe vision impairment, 360 million (322 to 400) will have mild vision impairment, and 866 million (629 to 1150) will have uncorrected presbyopia. Interpretation: Age-adjusted prevalence of blindness has reduced over the past three decades, yet due to population growth, progress is not keeping pace with needs. We face enormous challenges in avoiding vision impairment as the global population grows and ages.
Keywords: Global Burden of Disease Study; Vision loss expert group; Vision loss; Blindness; Vision impairment; Refractive error; Cataract; Glaucoma; Macular degeneration; Epidemiology.
Description: Published Online December 1, 2020
Rights: Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
DOI: 10.1016/S2214-109X(20)30425-3
Grant ID: EY018400
Published version: https://www.clinicalkey.com.au/#!/content/journal/1-s2.0-S2214109X20304253
Appears in Collections:Aurora harvest 4
Opthalmology & Visual Sciences publications

Files in This Item:
File Description SizeFormat 
hdl_133335.pdfPublished version602.52 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.